Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 9 | $278,721 |
Sells | 4 | $37,110 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
02 Nov 2023 21:21 | EIGR | Eiger BioPharmaceuticals Inc | KAYNE RICHARD A | 10% | 02 Nov 2023 | Purchase | 23,398 | 0.2977 | 6,966 | I |
02 Nov 2023 21:21 | EIGR | Eiger BioPharmaceuticals Inc | KAYNE RICHARD A | 10% | 01 Nov 2023 | Purchase | 100,000 | 0.2797 | 27,970 | I |
02 Nov 2023 21:21 | EIGR | Eiger BioPharmaceuticals Inc | KAYNE RICHARD A | 10% | 31 Oct 2023 | Purchase | 130,509 | 0.2414 | 31,505 | I |
02 Nov 2023 21:21 | EIGR | Eiger BioPharmaceuticals Inc | KAYNE RICHARD A | 10% | 31 Oct 2023 | Purchase | 12,345 | 0.2615 | 3,228 | I |
02 Nov 2023 21:21 | EIGR | Eiger BioPharmaceuticals Inc | KAYNE RICHARD A | 10% | 31 Oct 2023 | Purchase | 11,987 | 0.2625 | 3,147 | I |
02 Nov 2023 21:14 | EIGR | Eiger BioPharmaceuticals Inc | KAWAS LEEN | 10% | 31 Oct 2023 | Purchase | 12,345 | 0.2615 | 3,228 | I |
02 Nov 2023 21:14 | EIGR | Eiger BioPharmaceuticals Inc | KAWAS LEEN | 10% | 31 Oct 2023 | Purchase | 11,987 | 0.2625 | 3,147 | I |
21 Mar 2023 21:00 | EIGR | Eiger BioPharmaceuticals Inc | MAYER ELDON C. III | Ex VP & Chief Commerc. Officer | 17 Mar 2023 | Sale | 1,875 | 1.0707 | 2,008 | D |
21 Mar 2023 21:00 | EIGR | Eiger BioPharmaceuticals Inc | MAYER ELDON C. III | Ex VP & Chief Commerc. Officer | 17 Mar 2023 | Sale | 2,520 | 1.07 | 2,696 | D |
25 Jan 2023 20:54 | EIGR | Eiger BioPharmaceuticals Inc | DIETZ THOMAS JOHN | Director | 23 Jan 2023 | Purchase | 50,000 | 1.4316 | 71,580 | I |
03 Jan 2023 20:30 | EIGR | Eiger BioPharmaceuticals Inc | MURRAY CHRISTINE | Director | 29 Dec 2022 | Sale | 5,000 | 1.2208 | 6,104 | D |
27 Dec 2022 17:31 | EIGR | Eiger BioPharmaceuticals Inc | DIETZ THOMAS JOHN | Director | 22 Dec 2022 | Sale | 22,500 | 1.169 | 26,302 | D |
27 Dec 2022 17:31 | EIGR | Eiger BioPharmaceuticals Inc | GLENN JEFFREY S | Director | 22 Dec 2022 | Purchase | 100,000 | 1.2795 | 127,950 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)